The Cigna Group Registered Shs Aktie

299,89USD 0,07USD 0,02%
The Cigna Group Registered Shs für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A2PA9L / ISIN: US1255231003
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 73 700 73 700 71 300 72 500 0
Umsatz pro Mitarbeiter in Mio. EUR 2,18 2,36 2,52 2,69 0,00

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 27 799 36 134 30 120 37 351 0
Summe Anlagevermögen 122 986 114 890 109 788 110 575 0
Summe Aktiva 150 785 151 024 139 908 147 926 0

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 100 399 103 840 94 957 101 575 0
Summe Eigenkapital 50 386 47 184 44 951 46 351 41 033
Summe Passiva 150 785 151 024 139 908 147 926 0

Adresse

900 Cottage Grove Road, 06002-2920 Bloomfield
Telefon +1 (860) 226-6000
Internet http://www.cigna.com

Management

Brian C. Evanko
CFO, President & CEO-Cigna Healthcare
Chris DeRosa
President-United States Government
David J. Brailer
Chief Health Office & Executive Vice President
David Michael Cordani
Chairman, President & Chief Executive Officer
Donna F. Zarcone
Independent Director
Elder Granger
Independent Director
Eric C. Wiseman
Lead Independent Director
Eric J. Foss
Independent Director
Everett Neville
Executive VP-Strategy & Business Development
George Kurian
Independent Director
Jamie Kates
Chief Accounting Officer
Jason D. Sadler
President-International Markets
Kari Knight Stevens
Secretary, Chief Human Resources Officer & EVP
Kathleen M. Mazzarella
Independent Director
Kimberly A. Ross
Independent Director
Mark B. McClellan
Independent Director
Neesha Hathi
Independent Director
Nicole S. Jones
Chief Administrative Office, EVP & General Counsel
Noelle K. Eder
Global Chief Information Officer & Executive VP
Paul Sanford
Executive Vice President-Operations
Philip O. Ozuah
Independent Director
Ralph Giacobbe
Senior Vice President-Investor Relations
William J. DeLaney
Independent Director